课题基金 / 基金详情

Development and application of DNA tip for the diagnosis of atherogenic hypertriglyceridemia

Development and application of DNA tip for the diagnosis of atherogenic hypertriglyceridemia
DNA探针诊断动脉粥样硬化性高甘油三酯血症的开发及应用
批准号:
12670384
负责人:
IKEDA Yasuyuki
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

IKEDA Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mild hypertriglyceridemia (type IV hyperlipoproteinemia) is frequently identified in Japanese and is thought to be one of risk factors for heart disease. Mild hypertriglyceridemia results from superimposition of environmental factors, such as high alcohol intake and a hyperinsulinemic state, on a genetic state of a heterozygous mutation in the lipoprotein lipase (LPL) gene. Identification of heterozygote LPL gene mutations as an early determination of etiology underlying mild hypertriglyceridemia, therefore, is important for preventing the development of hypertriglyceridemia and subsequent development of heart disease by getting the patient to change to a more healthful lifestyle. Identification and collection of various LPL gene mutations are essential for the development ofDNA diagnostic tip for analysis ofLPL gene mutations. Results obtained at this (Research Project are listed bellow.(1) We developed an ELISA for the quantification of human LPL mass using two kinds of monoclonal an … More tibodies raised against human LPL, and improved method for direct DNA sequencing of the human LPL gene using an Auto DNA sequencer.(2) We newly identified LPL gene mutations, such as G105R, F270L, G154V and a T-to-C transition in the invariant GT at position +2 of the 5' donor splice site (5'-dss) ofintron 8 (Int8/5'-dss/t (+2) c) from Japanese subjects with mild hypertriglyceridemia. Also, we identified a mutation of D204E reported elsewhere. In missense mutations ofG105R, F270L, G154V and D204E, all mutants LPL expressed in COS-1 cells were catalytically inactive. Subjects with heterozygous LPL deficiency (carriers) are prone to develop type IV hyperlipoproteinemia when complicated with factors such as a hyperinsulinemic state and/or a high alcohol intake, which stimulate triglyceride synthesis in the liver, while carriers are normolipidemic provided that they do not have factors leading to hypertriglyceridemia.(3) So far, we have collected 15 mutations of the LPL gene by our Research projects including this project. Among 15 mutations, we have succeeded in identifying five mutations of Try-61-Stop, Asp-204-Glu, Ala-221-del, Ala-261 -Thr and Trp-382-Stop using Invader assay system (DNA diagnostic chip). Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
A. Mori: "Improved method for direct DNA sequencing of the human lipoprotein lipase gene using an auto DNA sequencer"Clinical Biochemistry. 33. 323-327 (2000)
A. Mori:“使用自动 DNA 测序仪对人脂蛋白脂肪酶基因进行直接 DNA 测序的改进方法”《临床生物化学》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
池田 康行: "Hypercholesterolemia, familial"先天異常症候群辞典(上巻). 59. 828-831 (2001)
Yasuyuki Ikeda:“家族性高胆固醇血症”先天性异常综合症词典(第 1 卷)。 828-831 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A. Takagi: "A newly identified lipoprotein lipase (LPL) gene mutationj (F270L) in a Japanese patient with familial LPL deficiency"Biochim. Biophys. Acta. 1502. 433-446 (2000)
A. Takagi:“在一名患有家族性 LPL 缺乏症的日本患者中新发现的脂蛋白脂肪酶 (LPL) 基因突变 j (F270L)”Biochim。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    動脈硬化性疾患の発症に直結する新規バイオマーカーの発見と早期診断・治療法の開発
    Establishment of genetic diagnostics, preventive and development of treatment for atherogenic hypertriglyceridemia
    Establishment of an early diagnostic system for the detection of heart disease-related gene mutations with a novel electrochemical array chip
    Molecular biological studies on the formation of atherogenic small dense low density lipoprotein (sLDL)
    海外基金